Renata PLC (DSE:RENATA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
500.50
0.00 (0.00%)
At close: Mar 27, 2025
-38.73%
Market Cap 57.41B
Revenue (ttm) 39.91B
Net Income (ttm) 2.96B
Shares Out 114.70M
EPS (ttm) 25.78
PE Ratio 19.41
Forward PE 22.96
Dividend 9.20 (1.84%)
Ex-Dividend Date Oct 22, 2024
Volume 41,409
Average Volume 20,072
Open 502.10
Previous Close n/a
Day's Range 500.00 - 503.40
52-Week Range 495.00 - 825.00
Beta 0.02
RSI 31.72
Earnings Date Apr 28, 2025

About Renata

Renata PLC manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, antiviral, a... [Read more]

Industry Pharmaceutical Preparations
Founded 1972
Employees 7,859
Stock Exchange Dhaka Stock Exchange
Ticker Symbol RENATA
Full Company Profile

Financial Performance

In 2024, Renata's revenue was 37.71 billion, an increase of 14.37% compared to the previous year's 32.97 billion. Earnings were 3.62 billion, an increase of 54.57%.

Financial Statements

News

There is no news available yet.